DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR METHYLPREDNISOLONE SODIUM SUCCINATE

« Back to Dashboard

Clinical Trials for Methylprednisolone Sodium Succinate

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00000579	Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)	Completed	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3	The purposes of this study are to assess rapidly innovative treatment methods in patients with adult respiratory distress syndrome (ARDS) as well as those at risk of developing ARDS and to create a network of interactive Critical Care Treatment Groups (CCTGs) to establish and maintain the required infrastructure to perform multiple therapeutic trials that may involve investigational drugs, approved agents not currently used for treatment of ARDS, or treatments currently used but whose efficacy has not been well documented.
NCT00290602	Early Low Dose Steroid Therapy of Acute Respiratory Distress Syndrome	Completed	National Cancer Center, Korea	Phase 2	The purpose of this study is to determine whether the 2mg/kg administration of corticosteroids, in the form of methylprednisolone sodium succinate, in early phase acute respiratory distress syndrome after thoracic surgery, will reduce the postoperative mortality.
NCT00295269	Corticosteroids as Rescue Therapy for the Late Phase of Acute Respiratory Distress Syndrome	Completed	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3	The purpose of this study is to assess innovative treatment methods in patients with adult respiratory distress syndrome (ARDS) as well as those at risk of developing ARDS.
NCT01046786	Safety and Feasibility of Umbilical Cord Blood Cell Transplant Into Injured Spinal Cord	Completed	Chinese University of Hong Kong	Phase 1/Phase 2	To investigate the feasibility, safety, efficacy and optimal dose of umbilical cord blood mononuclear cell transplant in the treatment of chronic spinal cord injuries.
NCT01046786	Safety and Feasibility of Umbilical Cord Blood Cell Transplant Into Injured Spinal Cord	Completed	The University of Hong Kong	Phase 1/Phase 2	To investigate the feasibility, safety, efficacy and optimal dose of umbilical cord blood mononuclear cell transplant in the treatment of chronic spinal cord injuries.

Clinical Trial Conditions for Methylprednisolone Sodium Succinate

Condition Name

Condition Name for Methylprednisolone Sodium Succinate
Intervention	Trials
Lung Diseases	2
Acute Respiratory Distress Syndrome	2
Spinal Cord Injuries	2
Neurotoxicity Syndrome	1

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Methylprednisolone Sodium Succinate
Intervention	Trials
Respiratory Distress Syndrome, Newborn	3
Respiratory Distress Syndrome, Adult	3
Acute Lung Injury	3
Syndrome	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Methylprednisolone Sodium Succinate

Trials by Country

Trials by Country for Methylprednisolone Sodium Succinate
Location	Trials
United States	67
Canada	9
Australia	5
New Zealand	2
Hong Kong	2

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Methylprednisolone Sodium Succinate
Location	Trials
North Carolina	3
Maryland	3
Massachusetts	3
Minnesota	2
Colorado	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Methylprednisolone Sodium Succinate

Clinical Trial Phase

Clinical Trial Phase for Methylprednisolone Sodium Succinate
Clinical Trial Phase	Trials
Phase 4	3
Phase 3	4
Phase 2	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Methylprednisolone Sodium Succinate
Clinical Trial Phase	Trials
Completed	7
Recruiting	2
Not yet recruiting	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Methylprednisolone Sodium Succinate

Sponsor Name

Sponsor Name for Methylprednisolone Sodium Succinate
Sponsor	Trials
National Cancer Institute (NCI)	2
National Heart, Lung, and Blood Institute (NHLBI)	2
China Spinal Cord Injury Network	2

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Methylprednisolone Sodium Succinate
Sponsor	Trials
Other	13
NIH	5

Export unavailable in trial.
Subscribe for complete access.